// App-Quantinova.ai

CT301 : A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Researchers

Presenter

  • Juanita S. Lopez

Principal Investigators

  • Marco Iafolla

  • Sylvie Rottey

  • Martin Schuler

  • Matthew Hellmann

  • Ani Balmanoukian

  • Luc Dirix

  • Michael Gordon

  • Ryan Sullivan

  • Brian S. Henick

  • Charles Drake

  • Kit Wong

  • Patricia Lo Russo

  • Patrick Ott

  • Lawrence Fong

  • Aglaia Schiza

  • Jeffery Yachnin

  • Christian Ottensmeier

  • Fadi Braiteh

  • Johanna Bendell

  • Rom Leidner

  • George Fisher

  • Guy Jerusalem

  • Laura Molenaar-Kuijsten

  • Marcus Schmidt

  • Scott A. Laurie

  • Raid Aljumaily

  • Achim Rittmeyer

  • Eelke Gort

  • Ignacio Melero

  • Lars Mueller

  • Rachel Sabado

  • Patrick Twomey

  • Jack Huang

  • Manesh Yadav

  • Jingbin Zhang

  • Felicitas Mueller

  • Evelyna Derhovanessian

  • Ugur Sahin

  • zlem Treci

  • Thomas Powles

Medical Centers

  • The Royal Marsden Hospital (Sutton, Surrey), Sutton, United Kingdom

  • University of Colorado Cancer Center, Aurora, CO

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • CRIG Ghent, Gent, Belgium

  • University Hospital of Essen, Essen, Germany

  • MSKCC, New York, NY

  • The Angeles Clinic and Research Institute, Santa Monica, CA

  • GZA Hospital Sint-Augustinus, Antwerp, Belgium.

  • HonorHealth Research Institute/TGen, Scottsdale, AZ

  • Dana-Farber/Harvard Cancer Center, Boston, MA

  • Columbia University, New York, NY

  • Seattle Cancer Care Alliance, Seattle, WA

  • Yale University, New Haven, CT

  • Dana-Farber Cancer Institute, Boston, MA

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Uppsala University Hospital, Uppsala, Sweden

  • Karolinska University Hospital, Stockholm, Sweden

  • University of Southampton, Southampten, United Kingdom

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN

  • Providence Cancer Center, Portland, OR

  • Stanford School of Medicine, Stanford, CA

  • CHU Liège and Liège University, Liège, Belgium

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Johannes-Gutenberg Universitat Mainz, Mainz, Germany

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

  • University of Oklahoma, Oklahoma City, OK

  • Lungenfachklinik Immenhausen, Immenhausen, Germany

  • UMC Utrecht, Utrecht, Netherlands

  • Centre of Applied Medical Research, Navarra, Spain

  • Genentech, Inc., South San Francisico, CA

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • BioNTech, Mainz, Germany

  • Bart's Cancer Institute, London, United Kingdom

Locations

  • United Kingdom

  • United States

  • Canada

  • Belgium

  • Germany

  • Sweden

  • Netherlands

  • Spain

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Atezolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved